Micro-environmental factors in the survival of human B-lymphoma cells

Cell Death and Differentiation

Volumn 7, Issue 1, 2000, Pages 59-69

  Levens, J M ^a   Gordon, J ^b   Gregory, C D ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

Apoptosis; B cell; Burkitt; Lymphoma; Macrophage; Micro environment

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CELL CONTACT; CELL SURVIVAL; CONTROLLED STUDY; DENDRITIC CELL; ENVIRONMENTAL FACTOR; FIBROBLAST; HUMAN; HUMAN CELL; LYMPHOMA CELL; MACROPHAGE; PHAGOCYTOSIS; PRIORITY JOURNAL; STROMA CELL;

EID: 0034114081     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400636     Document Type: Article

References (49)

1. Evan G and Littlewood T (1998) A matter of life and cell death. Science 281: 1317-1322
2. Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ and Hancock DC (1992) Induction of apoptosis in fibroblasts by c-myc protein. Cell 69: 119-128.
3. Harrington EA, Bennett MR, Fanidi A and Evan GI (1994) C-myc-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J. 13: 3286-3295
4. Magrath I (1990) The pathogenesis of Burkitt's lymphoma. Adv. Cancer Res. 55: 133-270
5. Gregory CD, Tursz T, Edwards CF, Tetaud C, Talbot M, Caillou B, Rickinson AB and Lipinski M (1987) Identification of a subset of normal B cells with a Burkitt's-lymphoma (BL)-like phenotype. J. Immunol. 139: 313-318
6. H and VL gene analysis in sporadic Burkitts lymphoma shows somatic hypermutation, intraclonal heterogeneity, and a role for antigen selection. Blood 88: 3562-3568
7. Rowe M, Rowe DT, Gregory CD, Young LS, Farrell PJ, Rupani H and Rickinson AB (1987) Differences in B-cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt lymphoma cells. EMBO J. 6: 2743-2751
8. Gregory CD, Rowe M and Rickinson AB (1990) Different Epstein-Barr virus-B-cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. J. Gen. Virol. 71: 1481-1495
9. Liu YJ, Mason DY, Johnson GD, Abbot S, Gregory CD, Hardie DL, Gordon J and Maclennan ICM (1991) Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur. J. Immunol. 21: 1905-1910
10. Henderson S, Rowe M, Gregory C, Groom-Carter D, Wang F, Longnecker R, Kieff E and Rickinson A (1991) Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 65: 1107-1115
11. Gregory CD, Dive C, Henderson S, Smith CA, Williams GT, Gordon J and Rickinson AB (1991) Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature 349: 612-614
12. Maclennan ICM (1994) Germinal-centers. Annu. Rev. Immunol. 12: 117-139
13. Milner AE, Grand RJA, Waters CM and Gregory CD (1993) Apoptosis in Burkitt lymphoma cells is driven by c-myc. Oncogene 8: 3385-3391
14. O'Conor GT (1961) Malignant lymphoma in African children. II. Pathological entity. Cancer 14: 270-283
15. Epstein MA and Herdson PB (1963) Cellular degeneration associated with characteristic nuclear fine structure changes in the cells from two cases of Burkitt's malignant lymphoma syndrome. Br. J. Cancer 17: 56-58
16. Cooper EH, Frank GL and Wright DH (1966) Cell proliferation in Burkitt tumours. Eur J. Cancer 2: 377-384
17. Berard C, O'Conor GT, Thomas LB and Torloni H (1969) Histopathological definition of Burkitt's tumour. Bull. World Health Org. 40: 601-607
18. Van den Eijnde SM, Boshart L, Reutelingsperger CPM, De Zeeuw CI and Vermeij-Keers C (1997) Phosphatidylserine plasma membrane asymmetry in vivo: A pancellular phenomenon which alters during apoptosis. Cell Death Differ. 4: 311-316
19. Savill J. The innate immune system: recognition of apoptotic cells. In: Gregory CD (ed) Apoptosis and the Immune Response. New York: Wiley-Liss, 1995, pp. 341-369
20. Gregory CD and Milner AE (1994) Regulation of cell survival in Burkitt lymphoma: Implications from studies of apoptosis following cold-shock treatment. Int. J. Cancer 57: 419-426
21. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY and Henson PM (1998) Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-/β, PGE2, and PAF. J. Clin. Invest. 101: 890-898
22. Kim H-S, Zhang XH and Choi YS (1994) Activation and proliferation of follicular dendritic cell-like cells by activated T lymphocytes. J. Immunol. 153: 2951-2961
23. Rooney CM, Gregory CD, Rowe M, Finerty S, Edwards C, Rupani H and Rickinson AB (1986) Endemic Burkitt's lymphoma-phenotypic analysis of tumor biopsy cells and of derived tumor cell lines. J. Natl. Cancer Inst. 77: 681-687
24. Garrone P, Neidhardt EM, Garcia E, Galibert L, Vankooten C and Vanchereau J (1995) Fas ligation induces apoptosis of CD40-activated human B lymphocytes. J Exp. Med. 182: 1265-1273
25. Flora PK and Gregory CD (1994) Recognition of apoptotic cells by human macrophages - inhibition by a monocyte/macrophage-specific monoclonal antibody. Eur. J. Immunol. 24: 2625-2632
26. Flora PK, Devitt A, Johnson GD, Milner AE and Gregory CD (1996) Bcl-2 delays macrophage engulfment of human B cells induced to undergo apoptosis. Eur. J. Immunol. 26: 2243-2247
27. Devitt A, Moffatt OD, Raykundalia C, Capra JD, Simmons DL and Gregory CD (1998) Human CD14 mediates recognition and phagocytosis of apoptotic cells. Nature 392: 505-509
28. Gordon J and Cairns JA (1991) Autocrine regulation of normal and malignant B lymphocytes. Adv. Cancer Res. 56: 313-334
29. Aubry JP, Pochon S, Graber P, Jansen KU and Bonnefoy JY (1992) CD21 is a ligand for CD23 and regulates IgE production. Nature 358: 505-507
30. Bonnefoy JY, Henchoz S, Hardie D, Holder MJ and Gordon J (1993) A subset of anti-CD21 antibodies promote the rescue of germinal center b-cells from apoptotis. Eur. J. Immunol. 23: 969-972
31. White LJ, Ozanne BW, Graber P, Aubry JP, Bonnefoy JY and Cushley W (1997) Inhibition of apoptosis in a human pre-B-cell line by CD23 is mediated via a novel receptor. Blood 90: 234-243
32. Grammer AC, Bergman MC, Miura Y, Fujita K, Davis LS and Lipsky PE (1995) The CD40 ligand expressed by human B cells costimulates B-cell responses. J. Immunol. 154: 4996-5010
33. Milner AE, Johnson GD and Gregory CD (1992) Prevention of programmed cell death in Burkitt lymphoma cell lines by bcl-2-dependent and bcl-2-independent mechanisms. Int. J. Cancer 52: 636-644
34. Wright DH (1963) Cytology and histochemistry of the Burkitt lymphoma. Br. J. Cancer 17: 50-55
35. Holder MJ, Wang H, Milner AE, Casamayor M, Armitage R, Spriggs MK, Fanslow WC, MacLennan ICM, Gregory CD and Gordon J (1993) Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of Bcl-2 induction. Eur. J. Immunol. 23: 2368-2371
36. Walker A, Taylor ST, Hickman JA and Dive C (1997) Germinal center-derived signals act with Bcl-2 to decrease apoptosis and increase clonogenicity of drug-treated human B lymphoma cells. Cancer Res. 57: 1939-1945
37. Baker MP, Eliopoulos AG, Young LS, Armitage RJ, Gregory CD and Gordon J (1998) Prolonged phenotypic, functional, and molecularchange in group I Burkitt lymphoma cells on short-term exposure to CD40 ligand. Blood 92: 2830-2843
38. Schattner EJ, Elkon KB, Yoo DH, Tumang J, Krammer PH, Crow MK and Friedman SM (1995) CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J. Exp. Med. 182: 1557-1565
39. McCloskey N, Pound JD, Holder MJ, Williams JM, Roberts LM, Lord JM and Gordon J (1999) The extrafollicular-to-follicular transition of human B lymphocytes: induction of functional globotriaosylceramide (CD77) on high threshold occupancy of CD40. Eur. J. Immunol. 29: 3236-3244
40. Falk MH, Hultner L, Milner A, Gregory CD and Bornkamm GW (1993) Irradiated fibroblasts protect Burkitt-lymphoma cells from apoptosis by a mechanism independent of bcl-2. Int. J. Cancer 55: 485-491
41. Falk MH, Meier T, Issels RD, Brielmeier M, Scheffer B and Bornkamm GW (1998) Apoptosis in Burkitt lymphoma cells is prevented by promotion of cysteine uptake. Int. J. Cancer 75: 620-625
42. Hall SE, Savill JS, Henson PM and Haslett C (1994) Apoptotic neutrophils are phagocytosed by fibroblasts with participation of the fibroblast vitronectin receptor and involvement of a mannose/fucose-specific lectin. J. Immunol. 153: 3218-3227
43. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR and Girkontaite I (1997) Immunosuppressive effects of apoptotic cells. Nature 390: 350-351
44. Macdonald I, Wang H, Grand R, Armitage RJ, Fanslow WC, Gregory CD and Gordon J (1996) Transforming growth factor-β1 cooperates with anti-immunoglobulin for the induction of apoptosis in group I (biopsy-like) Burkitt lymphoma cell lines. Blood 87: 1147-1154
45. Kumar A, Rogers T, Maizel A and Sharma S (1991) Loss of transforming growth factor beta-1 receptors and its effects on the growth of EBV-transformed human B cells. J. Immunol. 147: 998-1006
46. Piacebello W, Severino A, Stacchini A and Aglietta M (1991) Defferential effect of transforming growth factor-beta-1 on the proliferation of human lymphoid and myeloid-leukemia cells. Haematologica 76: 460-466
47. Milner AE, Grand RJA, Vaughan ATM, Armitage RJ and Gregory CD (1997) Differential effects of BCL-2 on survival and proliferation of human B-lymphoma cells following gamma-irradiation. Oncogene 15: 1815-1822
48. Wang H, Grand RJA, Milner AE, Armitage RJ, Gordon J and Gregory CD (1997) Repression of apoptosis in human B-lymphoma cells by CD40-ligand and Bcl-2: relationship to the cell-cycle and role of the retinoblastoma protein. Oncogene 13: 373-379
49. Dive C, Gregory CD, Phipps DJ, Evans DL, Milner AE and Wyllie AH (1992) Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry. Biochim. Biophys. Acta 1133: 275-285